These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9501749)

  • 1. Brain elimination half-life of fluvoxamine measured by 19F magnetic resonance spectroscopy.
    Strauss WL; Layton ME; Dager SR
    Am J Psychiatry; 1998 Mar; 155(3):380-4. PubMed ID: 9501749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder.
    Strauss WL; Layton ME; Hayes CE; Dager SR
    Am J Psychiatry; 1997 Apr; 154(4):516-22. PubMed ID: 9090339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human brain pharmacokinetics using a two-compartment model.
    Strauss WL; Layton ME; Dager SR
    Biol Psychiatry; 1999 May; 45(10):1384-8. PubMed ID: 10349045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy.
    Bolo NR; Hodé Y; Nédélec JF; Lainé E; Wagner G; Macher JP
    Neuropsychopharmacology; 2000 Oct; 23(4):428-38. PubMed ID: 10989270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo.
    Bolo NR; Hodé Y; Macher JP
    MAGMA; 2004 May; 16(6):268-76. PubMed ID: 15042463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
    Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
    J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of fluvoxamine.
    Perucca E; Gatti G; Spina E
    Clin Pharmacokinet; 1994 Sep; 27(3):175-90. PubMed ID: 7988100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
    Granfors MT; Backman JT; Neuvonen M; Ahonen J; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Apr; 75(4):331-41. PubMed ID: 15060511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive in vivo detection of a fluorinated neuroleptic in the human brain by 19F nuclear magnetic resonance spectroscopy.
    Durst P; Schuff N; Crocq MA; Mokrani MC; Macher JP
    Psychiatry Res; 1990 Dec; 35(2):107-14. PubMed ID: 2100803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by [19F]-nuclear magnetic resonance spectroscopy in vivo.
    Port R; Hanisch F; Becker M; Bachert P; Zeller J
    Cancer Chemother Pharmacol; 1999; 44(1):65-73. PubMed ID: 10367751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.
    Fleishaker JC; Hulst LK
    Eur J Clin Pharmacol; 1994; 46(1):35-9. PubMed ID: 8005185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo 19F-NMR study of isoflurane elimination from brain.
    Wyrwicz AM; Conboy CB; Ryback KR; Nichols BG; Eisele P
    Biochim Biophys Acta; 1987 Jan; 927(1):86-91. PubMed ID: 3790622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy.
    Christensen JD; Yurgelun-Todd DA; Babb SM; Gruber SA; Cohen BM; Renshaw PF
    Brain Res; 1999 Jul; 834(1-2):1-5. PubMed ID: 10407087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorinated blood substitute retention in the rat measured by fluorine-19 magnetic resonance imaging.
    Meyer KL; Carvlin MJ; Mukherji B; Sloviter HA; Joseph PM
    Invest Radiol; 1992 Aug; 27(8):620-7. PubMed ID: 1428740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration.
    van Harten J; Duchier J; Devissaguet JP; van Bemmel P; de Vries MH; Raghoebar M
    Clin Pharmacokinet; 1993 Feb; 24(2):177-82. PubMed ID: 8453824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination kinetics and symptomatology of diazepam withdrawal in abusers.
    Rhodes PJ; Rhodes RS; McCurdy HH
    J Toxicol Clin Toxicol; 1984; 22(4):371-85. PubMed ID: 6441848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.